PLoS ONE (Jan 2016)

Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.

  • Stine Skov Jensen,
  • Morten Meyer,
  • Stine Asferg Petterson,
  • Bo Halle,
  • Ann Mari Rosager,
  • Charlotte Aaberg-Jessen,
  • Mads Thomassen,
  • Mark Burton,
  • Torben A Kruse,
  • Bjarne Winther Kristensen

DOI
https://doi.org/10.1371/journal.pone.0159746
Journal volume & issue
Vol. 11, no. 7
p. e0159746

Abstract

Read online

AIMS:Glioblastoma is the most frequent and malignant brain tumor. Recurrence is inevitable and most likely connected to tumor invasion and presence of therapy resistant stem-like tumor cells. The aim was therefore to establish and characterize a three-dimensional in vivo-like in vitro model taking invasion and tumor stemness into account. METHODS:Glioblastoma stem cell-like containing spheroid (GSS) cultures derived from three different patients were established and characterized. The spheroids were implanted in vitro into rat brain slice cultures grown in stem cell medium and in vivo into brains of immuno-compromised mice. Invasion was followed in the slice cultures by confocal time-lapse microscopy. Using immunohistochemistry, we compared tumor cell invasion as well as expression of proliferation and stem cell markers between the models. RESULTS:We observed a pronounced invasion into brain slice cultures both by confocal time-lapse microscopy and immunohistochemistry. This invasion closely resembled the invasion in vivo. The Ki-67 proliferation indexes in spheroids implanted into brain slices were lower than in free-floating spheroids. The expression of stem cell markers varied between free-floating spheroids, spheroids implanted into brain slices and tumors in vivo. CONCLUSION:The established invasion model kept in stem cell medium closely mimics tumor cell invasion into the brain in vivo preserving also to some extent the expression of stem cell markers. The model is feasible and robust and we suggest the model as an in vivo-like model with a great potential in glioma studies and drug discovery.